BMRN vs GHI · P/E 40, rev $1.76B vs rev $43.0M
Biomarin Pharmaceutical Inc (BMRN) versus Greystone Housing Impact Investors LP (GHI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Greystone Housing Impact Investors LP (GHI) is a mortgage finance company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GHI revenue for 2026-06-30 was $43.0M. Net income was -$196.3K. Revenue was up 97.3% from 2026-03-31 to 2026-06-30. GHI currently screens at market cap $125.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GHI currently screens at market cap $125.1M.
Not investment advice. Open the BMRN and GHI stock pages for the full models.
Not investment advice.